Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma. 1977

Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima

Serum enzyme activities were studied in 131 cases of hepatocellular carcinoma (HCC), 76 cases of metastatic liver carcinomas (MLC) and 234 cases of hepatic cirrhosis. SGOT was elevated above SGPT in most of the time in these patients, SGOT/SGPT was greater in HCC compared with other groups, and that this ratio increased during the preterminal period more markedly in patients with HCC because of the significant increase of SGOT in the face of relatively stable SGPT. Preterminal rises of alkaline phosphatase and LDH activities were more pronounced in MLC. Leucine aminopeptidase activity exhibited no characteristic feature of diagnostic value. Of the five enzymes, SGOT changes were more closely correlated with the growth of HCC; SGPT reflected more of the liver parenchymal damage while SGOT was probably accounted for in part by tumor-derived GOT. Other clinical and pathological implications are discussed.

UI MeSH Term Description Entries
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D007931 Leucyl Aminopeptidase A zinc containing enzyme of the hydrolase class that catalyzes the removal of the N-terminal amino acid from most L-peptides, particularly those with N-terminal leucine residues but not those with N-terminal lysine or arginine residues. This occurs in tissue cell cytosol, with high activity in the duodenum, liver, and kidney. The activity of this enzyme is commonly assayed using a leucine arylamide chromogenic substrate such as leucyl beta-naphthylamide. Cytosol Aminopeptidase,Leucine Aminopeptidase,L-Leucylnaphthylamidase,Methoxyleucine Aminopeptidase,Peptidase S,Zinc-Manganese-Leucine Aminopeptidase,Aminopeptidase, Cytosol,Aminopeptidase, Leucine,Aminopeptidase, Leucyl,Aminopeptidase, Methoxyleucine,Aminopeptidase, Zinc-Manganese-Leucine,Zinc Manganese Leucine Aminopeptidase
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic

Related Publications

Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima
April 1959, The Journal of clinical endocrinology and metabolism,
Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima
February 1959, American review of tuberculosis,
Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima
June 1964, Clinical chemistry,
Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima
January 1967, Acta anaesthesiologica Scandinavica,
Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima
July 1963, Clinica chimica acta; international journal of clinical chemistry,
Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima
July 1961, The Ceylon medical journal,
Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima
April 1962, Journal of the Indian Medical Association,
Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima
July 1974, Zentralblatt fur Veterinarmedizin. Reihe A,
Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima
January 1979, Acta haematologica,
Y Shimokawa, and K Okuda, and Y Kubo, and A Kaneko, and T Arishima, and E Nagata, and M Hashimoto, and Y Sawa, and Y Nagasaki, and M Kojiro, and K Sakamoto, and T Nakashima
July 1957, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!